Matches in SemOpenAlex for { <https://semopenalex.org/work/W2556996985> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W2556996985 abstract "Cell division cycle 25 (CDC25) proteins are highly conserved dual specificity phosphatases that regulate the proper advancement of the cell cycle by activation of CDK/cyclin complexes. Overexpression of CDC25s, resulting in genomic instability and dysregulated cell growth, is frequently related to aggressiveness, high-grade tumors and poor prognosis. Thus, this family of enzymes represent an attractive target for drug discovery. Recently, compound 11, 3-(4,5,6-trihydroxy-3-oxo-3H-xanthen-9-yl)- propanoic acid, and compound 19, 4-(2-carboxybenzoyl)phthalic acid, were identified as novel inhibitors of CDC25s with a different inhibition profile, by using a structure-basedvirtual screening approach. Both compounds arrested cells at the G0/G1 and G2/M phases of the cell cycle, increased Cdk1 hyperphosphorylation in K562 leukemia cells,and significantly suppressed the growth of human MCF-7 breast, PC-3 prostate cancer lines as well as K562 leukemia cells, thus representing novel interesting leads. Thisthesis project focused on the computer-assisted lead optimization of the initial hits 11 and 19. Firstly, in order to expand our understanding of structure-activity relationships within the 6-xanthone class of CDC25 inhibitors, we identified a series of structuralanalogs of compound 11 by ligand-based chemoinformatic approach. We examined their activity against melanoma cancer cell lines, as well as the mechanism of actioninvolved. Nine compounds (3, 5–9, 21, 24, and 25) were identified with Ki values for CDC25A, -B and -C ranging from 0.01 to 4.4 μM. One of these analogs, 7, showed ahigh antiproliferative effect on human melanoma cell lines, A2058 and SAN, associated with an arrest in G2/M phase of the cell cycle. Furthermore, 7 induced apoptosisthrough intrinsic pathway. Interestingly, compound 7 decreased the protein levels of phosphorylated Akt and increased those of p53, thus contributing to the regulation of chemosensitivity through the control of downstream Akt pathways in melanoma cells. Secondly, a series of novel derivatives of compound 19 was rationally designed byusing a structure-based approach, guided by preliminary docking studies, with the aim to improve its binding affinity, pharmacokinetic properties as well as to investigate its anti-melanoma effect. A focused library of 24 derivatives was synthesized: a preliminary screening of the inhibitory activities toward CDC25B showed that ten molecules (compounds 2, 3d, 4, 4a, 4b, 5f, 6, 6a, 6b, 7) acted as powerful inhibitors with Ki values ranging between 2.8–20.1 μM. Among them, compounds 2 and 6a showed good antiproliferative effects on melanoma cell line A2058. Taken together, our data emphasize that CDC25 could be considered as a possible oncotarget in melanoma cells and that the designed compounds represent small molecule CDC25 inhibitors that merit to be further evaluated as chemotherapeutic agents for melanoma, likely in combination with other therapeutic compounds." @default.
- W2556996985 created "2016-11-30" @default.
- W2556996985 creator A5031786233 @default.
- W2556996985 date "2016-03-31" @default.
- W2556996985 modified "2023-09-27" @default.
- W2556996985 title "IDENTIFICATION OF NOVEL INHIBITORS OF CDC25 PHOSPHATASES AS NEW ANTI-MELANOMA AGENTS BY LIGAND- AND STRUCTURE-BASED VIRTUAL SCREENING STUDIES" @default.
- W2556996985 hasPublicationYear "2016" @default.
- W2556996985 type Work @default.
- W2556996985 sameAs 2556996985 @default.
- W2556996985 citedByCount "0" @default.
- W2556996985 crossrefType "journal-article" @default.
- W2556996985 hasAuthorship W2556996985A5031786233 @default.
- W2556996985 hasConcept C103697762 @default.
- W2556996985 hasConcept C105696609 @default.
- W2556996985 hasConcept C120504264 @default.
- W2556996985 hasConcept C124320809 @default.
- W2556996985 hasConcept C1491633281 @default.
- W2556996985 hasConcept C171122931 @default.
- W2556996985 hasConcept C184235292 @default.
- W2556996985 hasConcept C185592680 @default.
- W2556996985 hasConcept C2777228722 @default.
- W2556996985 hasConcept C2778198054 @default.
- W2556996985 hasConcept C2778583388 @default.
- W2556996985 hasConcept C29537977 @default.
- W2556996985 hasConcept C502942594 @default.
- W2556996985 hasConcept C55493867 @default.
- W2556996985 hasConcept C62112901 @default.
- W2556996985 hasConcept C74187038 @default.
- W2556996985 hasConcept C86803240 @default.
- W2556996985 hasConceptScore W2556996985C103697762 @default.
- W2556996985 hasConceptScore W2556996985C105696609 @default.
- W2556996985 hasConceptScore W2556996985C120504264 @default.
- W2556996985 hasConceptScore W2556996985C124320809 @default.
- W2556996985 hasConceptScore W2556996985C1491633281 @default.
- W2556996985 hasConceptScore W2556996985C171122931 @default.
- W2556996985 hasConceptScore W2556996985C184235292 @default.
- W2556996985 hasConceptScore W2556996985C185592680 @default.
- W2556996985 hasConceptScore W2556996985C2777228722 @default.
- W2556996985 hasConceptScore W2556996985C2778198054 @default.
- W2556996985 hasConceptScore W2556996985C2778583388 @default.
- W2556996985 hasConceptScore W2556996985C29537977 @default.
- W2556996985 hasConceptScore W2556996985C502942594 @default.
- W2556996985 hasConceptScore W2556996985C55493867 @default.
- W2556996985 hasConceptScore W2556996985C62112901 @default.
- W2556996985 hasConceptScore W2556996985C74187038 @default.
- W2556996985 hasConceptScore W2556996985C86803240 @default.
- W2556996985 hasLocation W25569969851 @default.
- W2556996985 hasOpenAccess W2556996985 @default.
- W2556996985 hasPrimaryLocation W25569969851 @default.
- W2556996985 hasRelatedWork W1705598372 @default.
- W2556996985 hasRelatedWork W1885676901 @default.
- W2556996985 hasRelatedWork W2003929352 @default.
- W2556996985 hasRelatedWork W2009133610 @default.
- W2556996985 hasRelatedWork W2018502914 @default.
- W2556996985 hasRelatedWork W2056840844 @default.
- W2556996985 hasRelatedWork W2166056968 @default.
- W2556996985 hasRelatedWork W2505859400 @default.
- W2556996985 hasRelatedWork W2536682856 @default.
- W2556996985 hasRelatedWork W2545727966 @default.
- W2556996985 hasRelatedWork W2799169574 @default.
- W2556996985 hasRelatedWork W2920810937 @default.
- W2556996985 hasRelatedWork W2973053519 @default.
- W2556996985 hasRelatedWork W3013978388 @default.
- W2556996985 hasRelatedWork W3091116918 @default.
- W2556996985 hasRelatedWork W3118326006 @default.
- W2556996985 hasRelatedWork W3146807722 @default.
- W2556996985 hasRelatedWork W3162500615 @default.
- W2556996985 hasRelatedWork W3199115261 @default.
- W2556996985 hasRelatedWork W595813438 @default.
- W2556996985 isParatext "false" @default.
- W2556996985 isRetracted "false" @default.
- W2556996985 magId "2556996985" @default.
- W2556996985 workType "article" @default.